P&K Skin Research Center Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Operating Revenue	22,783	17,847	14,843	17,957
Other Revenue	-0	-0	-	-
Revenue	22,783	17,847	14,843	17,957
Revenue Growth (YoY)	27.66%	20.24%	-17.34%	-
Cost of Revenue	12,113	9,409	7,668	6,865
Gross Profit	10,670	8,438	7,175	11,092
Selling, General & Admin	4,611	3,828	3,918	3,428
Research & Development	1,624	1,519	1,357	1,670
Other Operating Expenses	24.65	23.15	29.3	19.82
Operating Expenses	6,730	5,856	5,796	5,452
Operating Income	3,940	2,582	1,379	5,640
Interest Expense	-52.29	-26.49	-32.77	-25.77
Interest & Investment Income	2,997	3,753	3,808	2,215
Currency Exchange Gain (Loss)	-3.67	0.86	-0.29	0.03
Other Non Operating Income (Expenses)	-375.76	-224.19	63.36	546.89
EBT Excluding Unusual Items	6,505	6,085	5,217	8,377
Gain (Loss) on Sale of Investments	-760.03	712.69	140.01	-185.18
Gain (Loss) on Sale of Assets	5.58	-0.31	-0	-0.97
Pretax Income	5,751	6,797	5,357	8,190
Income Tax Expense	1,147	1,097	656.54	1,060
Earnings From Continuing Operations	4,604	5,701	4,700	7,130
Minority Interest in Earnings	81.77	115.58	112.75	-
Net Income	4,685	5,816	4,813	7,130
Net Income to Common	4,685	5,816	4,813	7,130
Net Income Growth	-19.45%	20.84%	-32.50%	-
Shares Outstanding (Basic)	29	29	30	30
Shares Outstanding (Diluted)	29	29	30	30
Shares Change (YoY)	-0.53%	-3.19%	0.58%	-
EPS (Basic)	162.22	200.32	160.48	239.12
EPS (Diluted)	162.22	200.32	160.48	239.12
EPS Growth	-19.02%	24.83%	-32.89%	-
Free Cash Flow	5,177	8,410	4,023	6,277
Free Cash Flow Per Share	179.25	289.65	134.13	210.50
Dividend Per Share	50.000	40.000	30.000	35.000
Dividend Growth	25.00%	33.33%	-14.29%	-
Gross Margin	46.84%	47.28%	48.34%	61.77%
Operating Margin	17.29%	14.47%	9.29%	31.41%
Profit Margin	20.57%	32.59%	32.43%	39.71%
Free Cash Flow Margin	22.72%	47.12%	27.10%	34.96%
EBITDA	5,994	4,431	3,114	7,108
EBITDA Margin	26.31%	24.83%	20.98%	39.59%
D&A For EBITDA	2,054	1,848	1,735	1,468
EBIT	3,940	2,582	1,379	5,640
EBIT Margin	17.29%	14.47%	9.29%	31.41%
Effective Tax Rate	19.95%	16.13%	12.26%	12.95%
Advertising Expenses	150.94	92.33	123.34	312.82

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.